Akt inhibitor Afuresertib, Purity ≥98%

Cat. No.: X24-05-ZQ182

Akt inhibitor Afuresertib, Purity ≥98%

Synonym: 1047644-62-1; GSK 2110183; GSK2110183; GSK-2110183; Akt inhibitor

  • CAS Number: 1047644-62-1
  • Compound CID: 46843057
Product Size
5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Afuresertib, soluble in DMSO and ethanol and insoluble in water, inhibits the phosphorylation of Akt with anti-inflammatory properties. It targets Akt1 E17K mutant, Akt2, Akt3, PKCη, PKCθ, PKC-βI, and ROCK.
Molecular Weight
427.32
Molecular Formula
C18H17Cl2FN4OS
Targets
Akt1 E17K mutant: 0.2 nM; Akt2: 2 nM (Ki); Akt3: 2.6 nM (Ki); PKCη: 210 nM (Ki); PKCθ: 510 nM; PKC-βI: 430 nM; ROCK: 100 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 79 mg/mL (184.87 mM); Water: Insoluble; Ethanol: 79 mg/mL (184.87 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Afuresertib can be used to study its inhibitory effect on Akt in cancer research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.